Effect of Shotblocker in Reducing Intramuscular Injection Pain in Adult Patients

NCT06624761 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-10-03

No results posted yet for this study

Summary

This randomized, double-blind study aimed to determine the effect of ShotBlocker on IMI pain in adult patients who received diclofenac sodium and metamizole sodium as IMI in the emergency department. The main question(s) it aims to answer are as follows:

• \[Is there a difference between the pain score averages between the intervention group and the control group after ShotBlocker? Participants \[Participants in both groups are individuals who applied to the emergency department and received IM injections according to the doctor\'s order.\] If there is a comparison group: Researchers will make a comparison with the control group.

Conditions

  • Patients Above 18 Years

Interventions

DEVICE

ShotBlocker

A randomized study investigating ShotBlocker in painkillers containing different active ingredients could not be found.

Sponsors & Collaborators

  • Toros University

    collaborator OTHER
  • Yağmur SÜRMELİ

    lead OTHER

Principal Investigators

  • YAGMUR SÜRMELI, DR. · Toros University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-14
Primary Completion
2024-12-30
Completion
2025-04-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06624761 on ClinicalTrials.gov